Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimizing Sysmex Technology as an Innovative Tool to Differentiate Between Malaria (PALUdism) and BACterial Infections in a Malaria Endemic Region

NCT02669823 is registered in ClinicalTrials.gov with Sysmex Europe GmbH as lead sponsor.

NCT NCT02669823
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02669823 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimizing Sysmex Technology as an Innovative Tool to Differentiate Between Malaria (PALUdism) and BACterial Infections in a Malaria Endemic Region
Lead sponsor
Sysmex Europe GmbH
Phase
Observational
Overall status
Completed
Start date
April 1, 2016
Completion date
June 30, 2017
Enrollment
930 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tropical infectious diseases